Schedule a Meeting
Get a SampleFebruary 2025
The U.S. DNA nanotechnology market size is calculated at USD 2.01 billion in 2025 and is forecasted to reach around USD 15.32 billion by 2034, accelerating at a CAGR of 25.26% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The U.S. DNA nanotechnology market size was estimated at USD 1.61 billion in 2024 and is predicted to increase from USD 2.01 billion in 2025 to approximately USD 15.32 billion by 2034, expanding at a CAGR of 25.26% from 2025 to 2034. The demand for DNA nanotechnology is increasing due to the rising medical applications that aim to produce advanced drug delivery systems for various treatments.
The presence of technologies like artificial intelligence and machine learning (ML) in the United States makes them dominant in the majority of industries, including healthcare. The use of AI is widely being adopted for structural designs which can eventually reduce the time required for trials and other experiments. The U.S. DNA nanotechnology market is anticipated to grow more rapidly due to the rising adoption of ML, which is helping to improve structural stability. Additionally, the rise of DNA computing is increasing the demand for AI, where the algorithms support the improvement of computational accuracy in the molecules.
DNA nanotechnology is a scientific field in which DNA molecules are used to build blocks, which are then turned into nanoscale structures and materials. This enables the use of these DNA chemicals and properties to engineer the architecture with precision. The U.S. DNA nanotechnology market is growing due to the expansion of structural DNA technology in the country which uses self-assembled DNA molecules into 2D and 3D structures. The need for these molecules in biomedical engineering is increasing due to the rising focus on drug delivery system improvements. The country is growing rapidly in the market due to increasing support from the National Nanotechnology Initiative (NNI).
| Report Coverage | Details |
| Market Size by 2034 | USD 15.32 Billion |
| Market Size in 2025 | USD 2.01 Billion |
| Market Size in 2024 | USD 1.61 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 25.26% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Type, Application, End-User. |
Growth in nanomedicine
The use of nanotechnology is being widely adopted due to several benefits that help in targeted drug deliveries. The major factor behind the growing demand is that technology helps in minimizing the side effects of the diseased cells which makes it more popular. The U.S. DNA nanotechnology market is expanding rapidly due to the increasing focus on developing advanced cancer therapies. The data from the American Cancer Society predicts that the country is expected to witness over 2 million cancer cases in the year 2025. This increases the use of nanomedicine, which can be used in other applications, including gene therapies.
Growth in DNA computing
The rise of DNA computing is playing a transformative role that enhances the production of efficient molecular computers. The U.S. DNA nanotechnology market is expanding rapidly due to the adoption of DNA computing as it has enabled high data storage density which is efficient for the companies. The growth is also helping parallel processing capabilities where all the functions and operations can be controlled at the same time. This helps in time consumption and also improves the productivity of the work cycle. American companies are highly adopting these methods to maximize their storage capabilities and increase the workflow which will help in generating more revenue share.
Higher development costs
The dominance of key industry players in the United States has marked significant revenue in recent years, but there are still some factors that tend to affect the country’s growth. Some DNA nanostructures are often higher in cost due to their complexity, which requires advanced equipment and other essential tools. The U.S. DNA nanotechnology market is anticipated to face certain challenges due to the higher R&D costs, which are unaffordable for SMEs. Additionally, these DNA are delicate and require constant maintenance which adds up to the costs.
Growth in personalized medicine
The technological presence among American countries plays an upper hand in innovating multiple drug delivery solutions for various therapies. The U.S. DNA nanotechnology market is anticipated to grow at a rapid pace due to the increasing focus on advanced targeted drug delivery based on the genetic profile of the patients. This is anticipated to attract more patients due to the increasing effectiveness of these therapies. The rising trend for early disease detection is also anticipated to increase the demand for DNA-based biosensors. The development of these sensors will help in detecting genetic profiles, which can help in the early diagnosis of diseases like cancer, Alzheimer's, and CAD. NIH is also focused on early detection and prevention, which will raise more revenue for these technological procedures.
Increasing investments in R&D
The United States is anticipated to witness rapid growth due to the rising initiatives from agencies like the National Institutes of Health, the National Science Foundation, and many more, which are investing heavily in nanomedicine and DNA computing. The pharmaceutical companies in the country are also investing in gene therapy, which is creating a collaborative environment for the companies and the research firms. The constant technological evolution is anticipated to help them in the structural improvement of the designs and simulations. The growing partnerships are enabling large-scale manufacturing which will eventually reduce the manufacturing costs in the longer run.
Type Insights
The structural DNA nanotechnology segment stood the dominant by registering the largest revenue share in 2024. The segment deals with designing and self-assembly of the DNA molecules into nanoscale structures. The U.S. DNA nanotechnology market is witnessing rapid due to the growing R&D investments in the country, which is backed by leading academic institutions like MIT, Harvard, and many others. Additionally, the healthcare industry in the country is also focused on drug delivery system improvements which focus on improving the effectiveness of the medicines. The growth is anticipated to expand in the coming years due to the increasing focus on DNA computing.
The dynamic DNA nanotechnology segment is anticipated to emerge as the fastest growing during the forecast period of 2025 to 2034. The demand for dynamic nanotechnology is increasing due to rising advancements that have availed self-assembly of the nanostructure and drug delivery, which fuels the growth. The ongoing advancements are also increasing the demand for targeted drug deliveries, which would be helpful in cancer treatments.
The targeted drug delivery segment marked its dominance by generating the largest revenue share in 2024. The application uses DNA nanostructures to transport the agents into the cells or tissues, which eventually reduces the damage to the other healthy cells. The U.S. DNA nanotechnology market is growing rapidly due to the rising chronic disease prevalence in the country. Additionally, the healthcare system in the country is gaining popularity for personalized therapies, which is boosting investments in these applications.
The smart pill segment is expected to rise as the fastest-growing segment during the forecast period of 2025 to 2034. The growth of the segment is mainly attributed to the rising adoption of remote monitoring where these pills are playing a crucial role in maintaining the bandwidth without the need for regular hospital visits. The increasing number of diabetic patients in the country will increase the demand in the upcoming years. The rising focus on long-term medical results is anticipated to create more business opportunities in biodegradable materials.
The biotechnology and pharmaceuticals segment accounted for the largest revenue share in the United States in 2024. The dominance of the segment is attributed to the growing focus on drug development and gene therapy. The U.S.-based agencies are investing heavily to improve the drug delivery systems which will boost the market growth in the upcoming years. Additionally, the growth of biosensors will also raise the demand for nanotechnology in the coming years.
The academic and research institutions segment is anticipated to excel as the fastest-growing segment from 2025 to 2034. The growth of the segment is attributed to the rising investment in universities and research centers that aim to advance in genomics and nanomedicine. These initiatives are anticipated to deliver high-end therapeutic solutions that would help towards the growth of the healthcare industry in the U.S. As a result, the government is increasing their partnerships and collaborations which would mark advancements through the use of technologies like AI and ML.
By Type
By Application
By End-user
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
February 2025
January 2025